NDRG1 and neuroblastoma: Considering this finding and the data obtained in the present and previous studies (Paukovcekova et al., 2020; Macsek et al., 2022), we suggest that the upregulation of NDRG1, which is detected after combined treatment with thiosemicarbazones and GEF or LAP, presents a promising strategy for neuroblastoma treatment.